Pharmaceuticals: Pfizer’s new Cork factory could play Covid role



Pfizer has obtained conditional planning approval to develop an early stage drug manufacturing facility for global clinical trials at its Ringaskiddy site, which may play a role in the pharmaceutical giant’s response to Covid-19.

fizer has received approval to develop the new clinical manufacturing facility, which is part of a € 300 million capital investment in its Irish operations announced last November, at the existing Pfizer site at Cork County Council .

Planning documents show that the development could lead to the creation of more than 100 jobs.

Pfizer’s new Ringaskiddy development will play a role in the manufacture of drugs for clinical trials. These are early stage drugs that are not yet approved by regulatory bodies. As of May, Pfizer had 99 potential new therapies in various stages of clinical trials in areas such as cancer, immunology, rare diseases and gene therapy.

The company is also working on a home Covid pill, which CEO Albert Bourla said could be available by the end of the year. Its Ringaskiddy plant could potentially be involved in the development of two ‘protease inhibitors’ for Covid-19, which are in an early-stage clinical trial, and could be part of the Covid-19 pill.

In May, Pfizer announced that its Grange Castle site in Dublin would become part of its Covid-19 vaccine supply chain as part of a new local investment of $ 40 million. It should create 75 jobs.

Pfizer said recruitment is underway for the new positions at Grange Castle, with a radio campaign set to begin next week, as well as Ringaskiddy. The positions will include engineers, biopharmaceutical manufacturing technicians, biopharmaceutical scientists and quality control technicians.

Pfizer also said its work on “technology transfer” regarding the Covid-19 vaccine is ongoing. He expects Grange Castle to be integrated into the vaccine network by the end of 2021.

The Grange Castle facility is ready to produce the mRNA drug substance. Grange Castle is one of Pfizer’s primary biological sites, employing 1,700 people and manufacturing biological drugs and vaccines.

Pfizer’s investment in Grange Castle is in addition to the investment program announced in November, which referred to the Ringaskiddy site. The ad also mentioned his Grange Castle site and that of Newbridge in County Kildare.



Leave A Reply